Skip to content
CompanySight
Company No. 11002642 · Incorporated 9 Oct 2017

Map Life Sciences Limited

Registered name: MAP LIFE SCIENCES LIMITED

Part of Kester Capital III GP LLP group

Map Life Sciences Limited does not publish its revenue or profit. Its accounts to 31 Dec 2024 show net assets of £273k.

Map Life Sciences Limited did not publish its revenue or profit — small companies aren’t required to file a profit & loss account. Its accounts for the year to 31 Dec 2024 showed net assets of £273k and 0 employees. The company is classified under “management consultancy activities other than financial management” and is based in Cambridge; we hold 3 years of its filed accounts.

Balance sheet onlySection M · Professional, scientific and technical activitiesSIC 70229Management consultancy activities other than financial management
Status
Active
Location
Cambridge, East of England
Age
9 yrs · since 2017
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2024

Key figures

Small team

Revenue not disclosed

Map Life Sciences Limited’s accounts for the year to 31 Dec 2024 contain a balance sheet but no profit & loss account, so its revenue and profit are not public. UK small and micro-entity companies are not required to publish a P&L — this is normal and says nothing about how the business is performing.

We never estimate revenue. Below you’ll find the balance-sheet figures that were filed — useful as indirect signals of momentum, but they are not revenue or profit.

Employees
0
Net assets
£273k

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

3 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Oct 202231 Oct 202331 Dec 2024
DisclosureNo P&LNo P&LNo P&L
Profit & loss
Revenue (turnover)———
Profit (best available)———
Employees (average)000
Ratios
Profit margin———
Balance sheet — indirect signals, not revenue
Cash at bank£7.4k£11.2k£2.4k
Net assets£187k£434k£273k
Fixed assets£19.1k£272k£271k
Current assets£212k£395k£838k
Debtors£205k£383k£836k
Deferred income£13.6k£5.7k£4.3k
SourceFullAccounts · bulk data May 2024FullAccounts · bulk data May 2024FullAccounts · bulk data Dec 2025
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
—
Now £273k
Cash at bank
—
Now £2.4k
Headcount
—
Now 0
Deferred income
—
Now £4.3k
Fixed assets
—
Now £271k

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

  1. Kester Capital III GP LLPultimate parent75–100%
  2. Mustang Topco Limited75–100%
  3. Mustang Midco Limited75–100%
  4. Mustang Bidco Limited75–100%
  5. Map Life Sciences Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Subsidiaries (1)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from FullAccounts for the year to 31 Dec 2024, from the Companies House accounts bulk data published Dec 2025. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.